We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOXA:NASDAQFox Corporation Analysis

Data as of 2026-05-22 - not real-time

$64.26

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fox Corporation (FOXA) is trading just above its short‑term moving averages, with the 20‑day SMA slightly below the current price and the 50‑day SMA just a touch lower. The MACD shows a bearish divergence, and the histogram is negative, suggesting downside pressure, while the overall trend remains neutral. Volume has been picking up, and the stock sits comfortably above a clear support zone but below a notable resistance level. Volatility over the past month is elevated, yet the beta remains low, indicating the share moves less than the broader market despite the price swings. The market sentiment index reads in the “Extreme Greed” territory, reflecting bullish investor appetite.
Fundamentally, the company posted a revenue dip year‑over‑year but delivered earnings per share well above consensus, driven by solid profit margins and a modest dividend payout. Cash generation exceeds debt obligations, and the payout ratio is comfortably low, supporting dividend sustainability. However, a discounted cash‑flow model places intrinsic value well below the current market price, flagging potential overvaluation. Analysts maintain a buy consensus, highlighting the forward earnings outlook and stable cash flow, while the dividend and defensive balance‑sheet traits add a value cushion.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat with higher‑than‑expected EPS
  • Bearish MACD divergence indicating near‑term downside risk
  • Price positioned above support but below key resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings growth and low forward PE relative to peers
  • Strong cash flow and low dividend payout ratio supporting sustainability
  • Analyst consensus trending bullish with a buy recommendation

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue contraction raises concerns about top‑line momentum
  • DCF valuation suggests the stock is priced well above intrinsic value
  • Stable dividend and defensive balance sheet provide a defensive floor

Key Metrics & Analysis

Financial Health

Revenue Growth-8.60%
Profit Margin10.56%
P/E Ratio16.9
ROE15.20%
ROA8.71%
Debt/Equity67.87
P/B Ratio2.5
Op. Cash Flow$2.6B
Free Cash Flow$1.4B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI52.0
Support$61.25
Resistance$68.25
MA 20$64.07
MA 50$61.87
MA 200$63.30
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value$34.10
Target Price$73.88
Upside/Downside14.97%
GradeOvervalued
TypeBlend
Dividend Yield0.87%

Risk Assessment

Beta0.44
Volatility30.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.